ghk-cu antibody formation immunogenicity risk An evidence-based strategy for assessing the of Implementing a Clinical Immunogenicity Strategy – ghk-cu antibody formation or neutralizing

Dermatologist-Reported Results In just 8 weeks: 81% experienced healthier overall skin* 71% saw improved hydration* 78% *Protocol: Clinically tested with dermatologist evaluation on 35 participants, ages 30-60, applying twice daily for 8 weeks

Store reconstituted peptide at 2-8 degrees Celsius (standard refrigerator temperature) and use within 4 weeks

A healthcare provider may prescribe the injection for patient-specific needs, but compounded products should only be used under medical supervision

Although activated charcoal may be an option for patients that present within FOUR HOURS post acetaminophen ingestion, preference is generally given to intravenous N-acetylcysteine

10.1016/j.jep.2020.113565 120 KaurM.GoelR